Senna (powdered): Target Organs and Levels of Evidence for GMM-15
Toxicology Study of Senna (CASRN 8013-11-4) in C57BL/6NTAC Mice and Toxicology and Carcinogenesis Study of Senna in Genetically Modified C3B6.129F1/Tac-Trp53tm1Brd N12 Haploinsufficient Mice (Feed Studies)
Chemical (Study Title) CASRN | Peer Review Date | Route/Exposure Levels | Study Laboratory |
---|---|---|---|
Senna (powdered) 8013-11-4 | 04/05/2011 | Dosed-Feed 0, 100, 300, 1000, 3000, or 10,000 ppm; 25/sex | Battelle Columbus Laboratory |
Male Heterozygous F1 p53+/− Mice | Female Heterozygous F1 p53+/− Mice | |
---|---|---|
40 Weeks | 40 Weeks | |
Levels of Evidence | No evidence | No evidence |
Neoplastic Lesions | None | None |
Non-Neoplastic Lesions |
|
|